Your healthcare provider will have to inform Cigna that you have performed behavioral modifications (e.g., increasing exercise) and a reduced-calorie diet for at least three months, and have either: A BMI of 30 or higher, or A BMI of 27 or higher, plus a weight-related comorbidity approved by Cigna, such as hypertension, Type 2 diabetes, dyslipidemia (high cholesterol), obstructive sleep apnea, or cardiovascular disease Wegovy is also FDA approved for cardiovascular risk reduction
Classical VKDB occurs between 24 hours and 7 days of life and is associated with delayed or insufficient feeding
10.1021/acs.chemrestox.5b00317 26 GroomH.LeeM.PatilP.JosephyP
For many patients who lost BCBS coverage, the jump from a $25 insurance copay to $1,000 monthly retail was simply not feasible
GLP-1 receptor agonists have become the fastest-growing weight loss category in medicine, with clinical trials demonstrating average weight reductions of 1522% over 68 weeks
Reactions between GLP-1 receptor agonists can vary widelyIve had patients who really cant tolerate one, but do just fine on another
